Keywords: kos, enters, cardiovascular, alliance, biovail, firm, pharmaceuticals

Kos enters cardiovascular R&D alliance with Biovail

Article | 09 May 2005

Print This

US firm Kos Pharmaceuticals has entered into a strategic commercialization and R&D alliance with Canada's Biovail Corp under which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in